Lantern Pharma Inc. Restricted Cash
Lantern Pharma Inc. (LTRN) had Restricted Cash of $541.18 thousand as of 2023-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Balance Sheet › Assets › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCash · last filed 2024-08-08
- 2023-06-30: Restricted Cash $541.18K.
- 2023-03-31: Restricted Cash $541.18K.
- 2022-12-31: Restricted Cash $541.18K.
- 2022-09-30: Restricted Cash $541.18K.
| Period end | Restricted Cash |
|---|---|
| 2023-06-30 | $541.18K 10-Q · filed 2024-08-08 |
| 2023-03-31 | $541.18K 10-Q · filed 2024-05-09 |
| 2022-12-31 | $541.18K 10-K · filed 2024-03-18 |
| 2022-09-30 | $541.18K 10-Q · filed 2023-11-08 |
| 2022-06-30 | $541.18K 10-Q · filed 2023-08-09 |
| 2022-03-31 | $541.18K 10-Q · filed 2023-05-09 |
| 2021-12-31 | $1.00M 10-K · filed 2023-03-20 |
| 2021-09-30 | $1.00M 10-Q · filed 2022-11-07 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |